Skip to content

    Nuvation Bio (NUVB) stock price & financials

    View NUVB earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+125.8% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $727.0K
    $5.71M
    $3.08M
    $4.83M
    $13.12M
    +1704.7%
    $41.87M
    +633.1%
    $83.23M
    +2598.7%
    $31.69M
    +555.6%
    Strengthening
    Operating Profit
    -$48.10M
    -$53.94M
    -$59.00M
    -$63.59M
    -$56.43M
    -17.3%
    -$34.04M
    +36.9%
    $3.88M
    -$51.04M
    +19.7%
    Strengthening
    Net Profit
    -$41.21M
    -$49.45M
    -$53.24M
    -$59.01M
    -$55.79M
    -35.4%
    -$36.59M
    +26.0%
    $5.40M
    -$62.84M
    -6.5%
    Strengthening
    EPS
    $-0.15
    $-0.16
    $-0.17
    $-0.16
    -6.7%
    $0.02
    $-0.18
    -5.9%
    Weakening
    Other Income
    $6.89M
    $4.50M
    $5.77M
    $4.58M
    $642.0K
    -90.7%
    -$2.56M
    -156.8%
    $1.52M
    -73.7%
    -$11.80M
    -357.6%
    Weakening
    Interest
    $120.0K
    $89.0K
    $54.0K
    $421.0K
    $6.53M
    +5345.0%
    $6.67M
    +7397.8%
    $6.71M
    +12322.2%
    $6.76M
    +1505.5%
    Strengthening
    Depreciation
    Profit before Tax
    -$41.21M
    -$49.45M
    -$53.24M
    -$59.01M
    -$55.79M
    -35.4%
    -$36.59M
    +26.0%
    $5.40M
    -$62.84M
    -6.5%
    Strengthening
    MarginsOPM
    -6616.4%
    -944.5%
    -1913.2%
    -1315.7%
    -430.1%
    +93.5%
    -81.3%
    +91.4%
    4.7%
    -161.1%
    +87.8%
    Strengthening
    Tax
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    ReturnsROIC
    28.2%
    33.9%
    36.5%
    40.4%
    38.2%
    +35.4%
    25.1%
    -26.0%
    -3.7%
    -110.1%
    43.1%
    +6.5%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$29.75M$132.42M$101.10M$42.65M$35.72M$164.09M$258.60M
    Short-Term Investments$186.00M$632.97M$559.91M$568.56M$466.97M$365.13M$402.35M
    Total Current Assets$220.68M$772.07M$667.32M$616.43M$526.25M$571.52M$726.43M
    Net PP&E$688.0K$3.66M$4.68M$4.32M$2.99M$4.48M$3.96M
    Goodwill
    Intangibles$0$4.62M$11.21M$10.29M
    Total Assets$221.79M$776.15M$672.14M$621.48M$540.63M$594.82M$744.50M
    LiabilitiesTotal Current Liabilities$6.55M$16.93M$13.16M$13.97M$58.24M$82.23M$86.75M
    Short-Term Debt$0$6.28M$5.72M$5.89M
    Long-Term Debt$47.21M$242.62M
    Long-Term Leases$2.19M$3.05M$2.04M$969.0K$2.54M$1.91M
    Total Liabilities$6.71M$30.15M$17.07M$16.36M$76.84M$289.11M$490.64M
    EquityCommon Stock & APIC$289.48M$909.99M$927.60M$947.75M$1.37B$1.42B$1.43B
    Retained Earnings-$75.95M-$162.80M-$267.00M-$342.80M-$910.74M-$1.12B-$1.17B
    Total Equity$215.08M$746.00M$655.08M$605.12M$463.79M$305.72M$253.86M
    HighlightsNet Cash / (Debt)$476.28M$412.44M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$36.53M-$68.19M-$96.11M-$68.00M-$130.41M-$173.43M-$120.52M
    Cash from Investing-$70.32M-$454.67M$63.46M$8.92M$122.70M$99.52M-$47.18M
    Cash from Financing$133.13M$625.53M$1.33M$628.0K$331.0K$202.53M$179.14M
    SummaryCapital Expenditure$0-$8.00M
    Free Cash Flow-$130.41M-$181.43M
    FCF Margin-1656.5%-288.4%

    Ratios